Jonathan Webster
8PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur
|Oct 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.Neil D Palmisiano, Ju-Whei Lee, David F Claxton
|Feb 06, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.Khaled Sanber, Kevin Ye, Hua-Ling Tsai
|Apr 05, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek
|Jul 21, 2021
A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).Jonathan A Webster, Meera Yogarajah, Marianna Zahurak
Pageof 2
Frequent Collaborators
3 joint publications
William B Dalton
3 joint publications
Tania Jain
2 joint publications
B Douglas Smith
1 joint publications
Cristina Correia
1 joint publications
Judith E Karp
1 joint publications
Scott H Kaufmann
1 joint publications
Khaled Sanber
1 joint publications
Neil D Palmisiano
1 joint publications
David F Claxton
1 joint publications
Hassan Alkhateeb
